tailieunhanh - The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer

An uninterrupted dose of oxaliplatin-based cytotoxic therapy is an essential component in the standard treatment regimen of metastatic colon cancer (mCC). Data on the impacts of dose intensity reduction on the palliative treatment for patients with mCC remain scarce. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN